Profil bibliographique

Yana Mangasarova

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

6Publications signalées

0Citations signalées

3Affiliations récentes

Les institutions déclarées

Russian New University National Medical Research Center for Hematology National Research Center for Hematology Russian Academy of Medical Sciences

Les domaines associés

Lymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and TreatmentCAR-T cell therapy researchChronic Lymphocytic Leukemia ResearchCutaneous lymphoproliferative disorders research

Les publications récentes

2026 article OpenAlex

ORAL ABSTRACT: HL-1412: PET-Guided Nivolumab-Based First-Line Strategy in Advanced-Stage Classical Hodgkin Lymphoma: Interim Clinical Results

Anna Kravtsova, Daria Koroleva, Olga Shchetsova, Madina Bagova et autres

ru (code pays fourni par la source)

0 citations Clinical Lymphoma Myeloma & Leukemia

2026 article OpenAlex

POSTER: HL-1412: PET-Guided Nivolumab-Based First-Line Strategy in Advanced-Stage Classical Hodgkin Lymphoma: Interim Clinical Results

Anna Kravtsova, Daria Koroleva, Olga Shchetsova, Madina Bagova et autres

ru (code pays fourni par la source)

0 citations Clinical Lymphoma Myeloma & Leukemia

2026 article OpenAlex

ABCL-1390: Addition of Fixed Low-Dose Nivolumab to R-DAEPOCH Is Associated With Improved Event-Free Survival in Newly Diagnosed Primary Mediastinal B-Cell Lymphoma

Runiza R. Abdurashidova, Yana Mangasarova, Elena Baryakh, Natalia Mikhaylova et autres

ru (code pays fourni par la source)

0 citations Clinical Lymphoma Myeloma & Leukemia

2026 article OpenAlex

POSTER: ABCL-1390: Addition of Fixed Low-Dose Nivolumab to R-DA-EPOCH Is Associated With Improved Event-Free Survival in Newly Diagnosed Primary Mediastinal B-Cell Lymphoma

Runiza R. Abdurashidova, Yana Mangasarova, Elena Baryakh, Natalia Mikhaylova et autres

ru (code pays fourni par la source)

0 citations Clinical Lymphoma Myeloma & Leukemia

2026 conference-abstract OpenAlex

HL-1412: PET-Guided Nivolumab-Based First-Line Strategy in Advanced-Stage Classical Hodgkin Lymphoma: Interim Clinical Results

Anna Kravtsova, Daria Koroleva, Olga Shchetsova, Madina Bagova et autres

ru (code pays fourni par la source)

0 citations Clinical Lymphoma Myeloma & Leukemia

Accès ouvert 2026 article OpenAlex

Real-world outcomes of glofitamab therapy in CAR-T–naïve patients with relapsed/refractory large B-cell lymphoma

Liudmila V. Fedorova, Natalia Mikhailova, Кирилл Лепик, Vladislav Markelov et autres

Glofitamab, demonstrated efficacy in patients with refractory diffuse large B-cell lymphoma. However, real-world data on glofitamab in other large B-cell lymphoma (LBCL) subtypes remain limited. This retrospective, multicenter study included 136 CAR-T naïve patients with relapsed and refractory LBCL who were treated …

ru (code pays fourni par la source)

0 citations Blood Immunology & Cellular Therapy

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.